Barely Significant
← all excerpts

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.

Cancers (Basel) · 2021 · PMC8038427 · PMID 33916610

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)
According to Kaplan–Meier curve analysis and the log-rank test, rs2230054 was significantly associated with the time from initial diagnosis to the diagnosis of metastatic disease ( p = 0.05), although the association with rs699947 did not reach statistical significance ( p = 0.07) ( Figure S3 ). 2.8.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.